Atlas FDA

REVISED DOUBLE ANTIBODY AMPHETAMINE

FDA 510(k) clearance K882228 · decided 1988-08-08

Clearance details

K-number
K882228
Device name
REVISED DOUBLE ANTIBODY AMPHETAMINE
Applicant
Diagnostic Products Corp.
Decision
Substantially Equivalent
Date received
1988-05-19
Decision date
1988-08-08
Days to decision
81 days
Clearance type
Traditional
Product code
DJP
Device class
2
Regulation number
862.3100
Medical specialty
Clinical Toxicology
Advisory committee
Clinical Toxicology
Location
Los Angeles, CA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Diagnostic Products Corp.

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
PRIMIDONE EIA TEST (K960526)Diagnostic Reagents, Inc.1996-03-18
URINE AMPHETAMINE DIRECT RIA KIT (I-125) (K913866)Immunalysis Corporation1991-09-25
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE (K912755)Roche Diagnostic Systems, Inc.1991-08-26
ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES (K881817)Roche Diagnostic Systems, Inc.1988-07-29
ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SP (K854009)Roche Diagnostic Systems, Inc.1985-10-15
ABUSCREEN RADIOIMMUNOASSAY-AMPHETAMINE (K830482)Hoffmann-La Roche, Inc.1983-03-24
ABUSCREEN RADIOIMMUNOASSAY - AMPHETAMINE (K823212)Hoffmann-La Roche, Inc.1982-11-29
AGGLUTEX AMPHETAMINE TEST KIT (K812986)Hoffmann-La Roche, Inc.1982-01-22

Recalls involving this device

No recalls on record reference this clearance.